TABLE 2.
ceh-39 acts upstream of xol-1
| Genotypea | Hermaphrodite viability (%)b | nc |
|---|---|---|
| ceh-39(y414) | 101 | 1008 |
| xol-1(y9)d | 97 | 1251 |
| ceh-39(y414) xol-1(y9)d | 93 | 1120 |
| dpy-27(y57) | 77 | 1164 |
| dpy-27(y57); xol-1(y9) | 77 | 1435 |
| dpy-27(y57); ceh-39(y414) | 18 | 1130 |
| dpy-27(y57); xol-1(y9) ceh-39(y414)d | 70 | 964 |
| sdc-2(RNAi) | 84 | 1512 |
| xol-1(y9) sdc-2(RNAi)d | 84 | 722 |
| ceh-39(y414) sdc-2(RNAi) | 53 | 1157 |
| ceh-39(y414) xol-1(y9) sdc-2(RNAi)d | 89 | 1416 |
a
RNAi was applied as explained in Table 1, footnote a.
b
Hermaphrodite viability was calculated by the following formula: (no. of adult hermaphrodites)/(total no. of embryos) × 100.
c
n is the total number of embryos from six independent sets of progeny counts.
d
Strain also includes the marker dpy-6(e14).